questionsmedicales.fr
Acides aminés, peptides et protéines
Acides aminés
Acides aminés soufrés
Cystéine
Acétylcystéine
Acétylcystéine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Gene Expression Profiling
Diagnostic
2
Acétylcystéine
Diagnostic médical
Tests de fonction pulmonaire
Acétylcystéine
Symptômes
2
Effets secondaires
Acétylcystéine
Prévention
2
Intoxication au paracétamol
Acétylcystéine
Prévention des infections
Acétylcystéine
Traitements
2
Maladies respiratoires
Acétylcystéine
Administration intraveineuse
Acétylcystéine
Complications
2
Réactions allergiques
Acétylcystéine
Interactions médicamenteuses
Acétylcystéine
Facteurs de risque
2
Allergies médicamenteuses
Acétylcystéine
Maladies respiratoires chroniques
Acétylcystéine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Acétylcystéine : Questions médicales les plus fréquentes",
"headline": "Acétylcystéine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Acétylcystéine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-13",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Acétylcystéine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cystéine",
"url": "https://questionsmedicales.fr/mesh/D003545",
"about": {
"@type": "MedicalCondition",
"name": "Cystéine",
"code": {
"@type": "MedicalCode",
"code": "D003545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.125.166.230"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Acétylcystéine",
"alternateName": "Acetylcysteine",
"code": {
"@type": "MedicalCode",
"code": "D000111",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David L Morris",
"url": "https://questionsmedicales.fr/author/David%20L%20Morris",
"affiliation": {
"@type": "Organization",
"name": "St George and Sutherland Clinical School, University of New South Wales Kogarah, Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Sarah J Valle",
"url": "https://questionsmedicales.fr/author/Sarah%20J%20Valle",
"affiliation": {
"@type": "Organization",
"name": "Mucpharm Pty Ltd, Kogarah Sydney, NSW, Australia."
}
},
{
"@type": "Person",
"name": "Krishna Pillai",
"url": "https://questionsmedicales.fr/author/Krishna%20Pillai",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia."
}
},
{
"@type": "Person",
"name": "Samina Badar",
"url": "https://questionsmedicales.fr/author/Samina%20Badar",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia."
}
},
{
"@type": "Person",
"name": "Javed Akhter",
"url": "https://questionsmedicales.fr/author/Javed%20Akhter",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gene expression profiling of",
"datePublished": "2024-05-06",
"url": "https://questionsmedicales.fr/article/38843019",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.36233/0507-4088-199"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gene Expression Profiling of Fibroepithelial Lesions of the Breast.",
"datePublished": "2023-05-20",
"url": "https://questionsmedicales.fr/article/37240386",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24109041"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gene expression profiling of monocytes in recent-onset schizophrenia.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37149105",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbi.2023.04.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retinoblastoma gene expression profiling based on bioinformatics analysis.",
"datePublished": "2023-05-13",
"url": "https://questionsmedicales.fr/article/37179305",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12920-023-01537-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expression Profiles of Dopamine-Related Genes and miRNAs Regulating Their Expression in Breast Cancer.",
"datePublished": "2024-06-14",
"url": "https://questionsmedicales.fr/article/38928253",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25126546"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides aminés",
"item": "https://questionsmedicales.fr/mesh/D000596"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides aminés soufrés",
"item": "https://questionsmedicales.fr/mesh/D000603"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cystéine",
"item": "https://questionsmedicales.fr/mesh/D003545"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acétylcystéine",
"item": "https://questionsmedicales.fr/mesh/D000111"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Acétylcystéine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Acétylcystéine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Acétylcystéine",
"description": "Comment l'acétylcystéine est-elle utilisée dans le diagnostic ?\nQuels tests peuvent nécessiter l'acétylcystéine ?",
"url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Gene+Expression+Profiling#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Acétylcystéine",
"description": "Quels symptômes l'acétylcystéine aide-t-elle à soulager ?\nQuels effets secondaires peuvent survenir ?",
"url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Gene+Expression+Profiling#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Acétylcystéine",
"description": "L'acétylcystéine peut-elle prévenir des complications ?\nComment l'acétylcystéine aide-t-elle en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Gene+Expression+Profiling#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Acétylcystéine",
"description": "Dans quels cas l'acétylcystéine est-elle prescrite ?\nComment l'acétylcystéine est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Gene+Expression+Profiling#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Acétylcystéine",
"description": "Quelles complications peuvent survenir avec l'acétylcystéine ?\nL'acétylcystéine peut-elle interagir avec d'autres médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Gene+Expression+Profiling#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Acétylcystéine",
"description": "Qui devrait éviter l'acétylcystéine ?\nQuels facteurs augmentent le risque d'effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Gene+Expression+Profiling#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment l'acétylcystéine est-elle utilisée dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à évaluer la fonction pulmonaire en fluidifiant les sécrétions bronchiques."
}
},
{
"@type": "Question",
"name": "Quels tests peuvent nécessiter l'acétylcystéine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire peuvent être réalisés pour évaluer l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Quels symptômes l'acétylcystéine aide-t-elle à soulager ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle soulage la toux et les difficultés respiratoires dues à des sécrétions épaisses."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent survenir ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, vomissements ou éruptions cutanées peuvent se produire chez certains patients."
}
},
{
"@type": "Question",
"name": "L'acétylcystéine peut-elle prévenir des complications ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut prévenir des lésions hépatiques en cas d'intoxication au paracétamol."
}
},
{
"@type": "Question",
"name": "Comment l'acétylcystéine aide-t-elle en prévention ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle réduit la viscosité des sécrétions, facilitant leur élimination et prévenant les infections."
}
},
{
"@type": "Question",
"name": "Dans quels cas l'acétylcystéine est-elle prescrite ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est prescrite pour traiter les maladies respiratoires et les overdoses de paracétamol."
}
},
{
"@type": "Question",
"name": "Comment l'acétylcystéine est-elle administrée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être administrée par voie orale ou intraveineuse, selon la situation clinique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'acétylcystéine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves, bien que rares, peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "L'acétylcystéine peut-elle interagir avec d'autres médicaments ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut interagir avec certains antibiotiques et médicaments anticoagulants."
}
},
{
"@type": "Question",
"name": "Qui devrait éviter l'acétylcystéine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes allergiques à l'acétylcystéine ou ayant des antécédents d'asthme sévère."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies et les maladies respiratoires chroniques peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
St George and Sutherland Clinical School, University of New South Wales Kogarah, Sydney, NSW, Australia.
Mucpharm Pty Ltd, Kogarah Sydney, NSW, Australia.
Department of Surgery, St George Hospital Kogarah, NSW, Australia.
Publications dans "Acétylcystéine" :
3 publications dans cette catégorie
Affiliations :
Mucpharm Pty Ltd, Kogarah Sydney, NSW, Australia.
Intensive Care Unit, St George Hospital Kogarah, NSW, Australia.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia.
Mucpharm Pty Ltd Australia.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia.
University of New South Wales, St George & Sutherland Clinical School Sydney, NSW 2217, Australia.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia.
Mucpharm Pty Ltd Australia.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia.
Mucpharm Pty Ltd Australia.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Centro Cardiologico Monzino IRCCS, Unit of Functional Proteomics, Metabolomics, and Network Analysis, 20138 Milan, Italy.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Centro Cardiologico Monzino IRCCS, Unit of Functional Proteomics, Metabolomics, and Network Analysis, 20138 Milan, Italy.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Nacuity Pharmaceuticals, Inc., Fort Worth, Texas, USA.
Publications dans "Acétylcystéine" :
2 publications dans cette catégorie
Affiliations :
Clinical Toxicology, Pharmacology and Toxicology, Queen's Medical Research Institute, University of Edinburgh, UK.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
St George and Sutherland Clinical School, University of New South Wales Kogarah, Sydney, NSW, Australia.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia.
Mucpharm Pty Ltd Australia.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
University of New South Wales, St George & Sutherland Clinical School Sydney, NSW 2217, Australia.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Mucpharm Pty Ltd Australia.
Service de Chirurgie Digestive et Endocrinienne, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France; EMR 3738, Lyon 1 Université Lyon, France.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Division of Psychodermatology, Central Michigan University, Saginaw, Michigan.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Division of Psychodermatology, Central Michigan University, Saginaw, Michigan.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Department of Dentistry for Children and Disabled Persons, Graduate School of Dental Medicine, Hokkaido University.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Department of Dentistry for Cellular and Molecular Pharmacology Section, Graduate School of Dental Medicine, Hokkaido University.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Department of Dentistry for Children and Disabled Persons, Graduate School of Dental Medicine, Hokkaido University.
Publications dans "Acétylcystéine" :
1 publication dans cette catégorie
Affiliations :
Department of Dentistry for Cellular and Molecular Pharmacology Section, Graduate School of Dental Medicine, Hokkaido University.
Publications dans "Acétylcystéine" :
The HTLV-1 infection persists for life, remaining as asymptomatic viral reservoirs in most patients, ensuring the chain of transmission, but around 4% develop adult T-cell leukemia/lymphoma (ATLL). HT...
We conducted this study on the prevalence of HTLV-1 infection in blood donors to expand the HTLV-1 database, assess the risk of transmission via blood products, as well as evaluate the risk of persist...
This is a cross-sectional study of blood donors of all categories. For this study, 265 blood donors were recruited at the Centre National de Transfusion Sanguine in Brazzaville. After testing for HTLV...
20/265 were positive for anti-HTLV-1 antibody, 5 donors were positive for proviral DNA. The prevalence of HTLV-1 was 1.8%. All HTLV-1-positive donors were male (1.8%), with a positive correlation (...
The prevalence, though low, remains a serious problem. No abnormal...
Fibroepithelial lesions of the breast (FELs) are a heterogeneous group of neoplasms exhibiting a histologic spectrum ranging from fibroadenomas (FAs) to malignant phyllodes tumors (PTs). Despite publi...
Immune-related mechanisms have been suggested to be involved in schizophrenia. Various studies have shown changes in monocytes isolated from the blood of schizophrenia patients, including changes in m...
Retinoblastoma (RB) is frequently occurring malignant tumors that originate in the retina, and their exact cause and development mechanisms are yet to be fully comprehended. In this study, we identifi...
In this study GSE110811 and GSE24673 were analyzed. Weighted gene co-expression network analysis (WGCNA) was applied to screen modules and genes associated with RB. By overlapping RB-related module ge...
About 133 DERBGs were found to be associated with RB. GO and KEGG enrichment analyses revealed that the important pathways of these DERBGs. Furthermore, the PPI network revealed 82 DERBGs interacting ...
Hub DERBGs may provide new insight into RB diagnosis and treatment based on the understanding of disease pathogenesis....
This study aimed to assess the expression profile of messenger RNA (mRNA) and microRNA (miRNA) related to the dopaminergic system in five types of breast cancer in Polish women. Patients with five bre...
In this Perspective, we discuss the current status and advances in spatial transcriptomics technologies, which allow high-resolution mapping of gene expression in intact cell and tissue samples. Spati...
Although gene expression signatures offer tremendous potential in diseases diagnostic and prognostic, but massive gene expression signatures caused challenges for experimental detection and computatio...
Expressional profiling of the endometrium enables the personalised timing of the window of implantation (WOI). This study presents and evaluates a novel analytical pipeline based on a TAC-seq (Targete...
There is a lack of effective diagnostic biomarkers for neurodegenerative disorders (NDDs). Here, we established gene expression profiles for diagnosing Alzheimer's disease (AD), Parkinson's disease (P...
Glioblastoma (GBM) is the most lethal primary tumor in the human brain and lacks favorable treatment options. Sex differences in the outcome of GBM are broadly acknowledged, but the underlying molecul...